New Hope For Alzheimer’s From Local Pharma Company

Shanghai-based Green Valley is going through a fast-tracked approval process for its GV-971 drug, which it says is the world’s first multi-targeting drug for the treatment of mild to moderate Alzheimer’s disease.

 

Video Source: Shanghai Live, ICS